COVID-19: is there a link between the course of infection and pharmacological agents in diabetes?
Tiziana Filardi, Susanna Morano
Topics & Concepts
Dipeptidyl peptidase-4Diabetes mellitusCoronavirusMedicineType 2 diabetesMiddle East respiratory syndrome coronavirusPneumoniaCase fatality rateImmunologyDiseaseImmune systemReceptorInternal medicineEndocrinologyCoronavirus disease 2019 (COVID-19)EpidemiologyInfectious disease (medical specialty)COVID-19 Clinical Research StudiesPharmacological Receptor Mechanisms and EffectsSARS-CoV-2 and COVID-19 Research